Skip to content
OpenCapital
Get started

Precision BioSciences, Inc. DTIL Q1 2026 earnings

Reported May 5, 2026 · Before market open

Revenue$10.8MBeat by $6.8M
EPS-$0.34Miss by $0.07
Revenue estimate$4.1M
EPS estimate-$0.27

Next report

Aug 6, 2026 (In 1 week)
Revenue estimate$1.4M
EPS estimate-$0.71

Versus estimates

Revenue

Q1 2026$10.8MBeat by $6.8M
Q4 2025$34.2MBeat by $25.1MQ3 2025$13.0KMiss by $9.1MQ2 2025$18.0KMiss by $5.4MQ1 2025$29.0KMiss by $6.2MQ4 2024$638.0KMiss by $9.4M

Diluted EPS

Q1 2026-$0.34Miss by $0.07
Q4 2025$0.36Beat by $0.57Q3 2025-$1.84Miss by $1.53Q2 2025-$2.13Miss by $2.04Q1 2025-$2.21Miss by $1.78Q4 2024-$3.20Miss by $1.11

Ask the moment Precision BioSciences, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Precision BioSciences, Inc. report Q1 2026 earnings?
Precision BioSciences, Inc. (DTIL) reported Q1 2026 earnings on May 5, 2026 before market open.
What were Precision BioSciences, Inc.'s Q1 2026 revenue and EPS?
Precision BioSciences, Inc. reported revenue of $10.8M and eps of $-0.34 for Q1 2026.
Did Precision BioSciences, Inc. beat estimates in Q1 2026?
Revenue beat the consensus estimate of $4.1M by $6.8M. EPS missed the consensus estimate of $-0.27 by $0.07.
How did Precision BioSciences, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 37272.4% from $29.0K a year earlier and eps grew 84.6% from $-2.21.
Where can I find Precision BioSciences, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-030123) and the 10-Q periodic report (0001628280-26-030124) directly on SEC EDGAR. The filing index links above go to sec.gov.